CFIP
HBIO icon

Chicago Fundamental Investment Partners’s Harvard Bioscience HBIO Stock Holding History

Chicago Fundamental Investment Partners’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$97K Buy
2,426
+541
+29% +$21.3K 0.26% 9
2013
Q2 		$67K Buy
+1,885
New +$72.2K 0.15% 10

Other funds holding HBIO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Chicago Fundamental Investment Partners's HBIO Position: Q3 2013 in Review

Chicago Fundamental Investment Partners increased its Harvard Bioscience (HBIO) stake by 29% in Q3 2013, buying an estimated $21.3K and bringing the position to 2,426 shares worth $97K. The position accounts for 0.26% of the portfolio, ranked #9.

Chicago Fundamental Investment Partners first reported a position in HBIO in Q2 2013 and has held it in 2 quarters since. 81 funds tracked by Wall St. Rank hold HBIO as of Q3 2013.

  • Chicago Fundamental Investment Partners held 2,426 shares of Harvard Bioscience worth $97K as of Q3 2013.
  • Chicago Fundamental Investment Partners bought 541 Harvard Bioscience shares in Q3 2013, an estimated $21.3K.
  • Harvard Bioscience made up 0.26% of Chicago Fundamental Investment Partners's portfolio in Q3 2013, its #9 holding.
  • Chicago Fundamental Investment Partners first reported a position in Harvard Bioscience in Q2 2013 and has held it in 2 quarters since.
  • 81 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2013.

Based on Chicago Fundamental Investment Partners's 13F filing for Q3 2013, filed 13 Nov 2013.